News & Updates

Short nighttime sleepers are at higher risks of long COVID, depression and cardiovascular (CV) diseases than normal sleepers, according to three recent studies by researchers from the Chinese University of Hong Kong (CUHK).

Long-term treatment with methylphenidate does not increase risks of growth impairment and psychiatric or neurological adverse events (AEs) in children and adolescents with attention deficit hyperactivity disorder (ADHD), according to the international ADDUCE study co-led by the University of Hong Kong (HKU) and the University of Melbourne.

A tumour immune barrier (TIB) structure formed by the interaction of SPP1+ macrophages and cancer-associated fibroblasts (CAFs) appears to influence the efficacy of immunotherapy in patients with hepatocellular carcinoma (HCC), reveals a study.

Treatment with secukinumab leads to sustained clinical response among patients with psoriasis, with clinical response being associated with rapid and persistent normalization of keratin 16 (K16) and inflammatory gene expression for most patients, according to data from the ObePso-S study.

A population-based, multicentre study finds female gender, transportation-, logistics- or discipline-related occupation, living with domestic workers, smoking, poor or very poor self-perceived health status, ≥3 chronic diseases, chronic medication use, and critical severity of COVID-19 to be associated with severe long COVID, while prior receipt of ≥2 doses of COVID-19 vaccines serves as a protective factor.

The effects of systemic antihypertensive medications on glaucoma and intraocular pressure (IOP) appear to vary widely, according to the results of a systematic review and meta-analysis.